Term Contract Clauses (29,682)

Term. You may not exercise your option before the Date of Grant or after the expiration of the option's its term. The term of your option expires, subject to the provisions terms of Section 5(h) of the Plan, upon the earliest of the following: (a) immediately upon the termination of your Continuous Service for Cause; (b) three months after the termination of your Continuous Service for any reason other than Cause, your Disability or your death (except as otherwise provided in Section 8(d) below); 8(d)); provided, however, that if during any part of such three month period your option is not exercisable solely because of the condition set forth in the section above relating to 4. "Securities Law Compliance," your option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three months after the termination of your Continuous Service; provided further, if during any part of such three (3) month period, the sale of any Common Stock received upon exercise of your option would violate the Company's insider trading policy, then your option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three (3) months after the termination of your Continuous Service during which the sale of the Common Stock received upon exercise of your option would not be in violation of the Company's insider trading policy. Notwithstanding the foregoing, if (i) you are a Non-Exempt Employee, (ii) your Continuous Service terminates within six months after the Date of Grant, and (iii) you have vested in a portion of your option at the time of your the termination of your Continuous Service, your option will not expire until the earlier of (x) (A) the later of (A) (1) the date that is seven months after the Date of Grant, and (B) (2) the date that is three months after the termination of your Continuous Service, and (y) (B) the Expiration Date; Date set forth in your Grant Notice; (c) 12 twelve months after the termination of your Continuous Service due to your Disability (except as otherwise provided in Section 8(d)) below; 8(d)); (d) 18 eighteen months after your death if you die either (i) during your Continuous Service or Service, (ii) within three months after the termination of your Continuous Service terminates for any reason other than Cause; Cause or your Disability, or (iii) within twelve months after the termination of your Continuous Service for your Disability; (e) the Expiration Date indicated in your Grant Notice; or (f) the day before the 10th tenth anniversary of the Date of Grant. If your option is an Incentive Stock Option, note that to obtain the federal income tax advantages associated with an Incentive Stock Option, the Code requires that at all times beginning on the Date of Grant and ending on the day three months before the date of you exercise your option's exercise, option, you must be an employee of the Company or an Affiliate, except in the event of your death or your permanent and total Disability. The Company has provided for extended exercisability of your option under certain some circumstances for your benefit but cannot guarantee that your option will necessarily be treated as an Incentive Stock Option if you continue to provide services to the Company or an Affiliate as a Consultant or Director after your employment terminates or if you otherwise exercise your option more than three months after the date your employment with the Company or an Affiliate terminates. View More

Term. You may not exercise your option before the Date of Grant or after the expiration of the option's term. The term of your option expires, subject to the provisions of Section 5(h) of the Plan, expires upon the earliest of the following: (a) if your Continuous Service is terminated for Cause, then immediately upon the date on which the event giving rise to the termination of your Continuous Service for Cause; Cause first occurred; (b) three (3) months after the termination of your Continuous... Service for any reason other than Cause, your Disability or your death (except as otherwise provided in Section 8(d) below); provided, however, that if during any part of such three (3) month period your option is not exercisable solely because of the condition set forth in the section above relating to 4. "Securities Law Compliance," your option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three months after the termination of your Continuous Service; provided further, if during any part of such three (3) month period, the sale of any Common Stock received upon exercise of your option would violate the Company's insider trading policy, then your option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three (3) months after the termination of your Continuous Service during which the sale of the Common Stock received upon exercise of your option would not be in violation of the Company's insider trading policy. Notwithstanding the foregoing, if (i) you are a Non-Exempt Employee, (ii) your Continuous Service terminates within six months after the Date of Grant, and (iii) you have vested in a portion of your option at the time of your termination of Continuous Service, your option will not expire until the earlier of (x) the later of (A) the date that is seven months after the Date of Grant, and (B) the date that is three months after the termination of your Continuous Service, and (y) the Expiration Date; Service; (c) 12 twelve (12) months after the termination of your Continuous Service due to your Disability (except as otherwise provided in Section 8(d)) 6(d)) below; (d) 18 eighteen (18) months after your death if you die either during your Continuous Service or within three (3) months after your Continuous Service terminates for any reason other than Cause; (e) the Expiration Date indicated in your Grant Notice; or (f) the day before the 10th tenth (10th) anniversary of the Date of Grant. If and to the extent your option is an Incentive Stock Option, note that to obtain the federal income tax advantages associated with an Incentive Stock Option, the Code requires that at all times beginning on the Date of Grant and ending on the day three (3) months before the date of your option's exercise, you must be an employee of the Company or an Affiliate, except in the event of your death or Disability. The Company has provided for extended exercisability of your option under certain circumstances for your benefit but cannot guarantee that your option will necessarily be treated as an Incentive Stock Option if you continue to provide services to the Company or an Affiliate as a Consultant or Director after your employment terminates or if you otherwise exercise your option more than three (3) months after the date your employment with the Company or an Affiliate terminates. View More

Term. You may not exercise your option before the Date of Grant or after the expiration of the option's term. The term of your option expires, subject to the provisions of Section Sections 5(h) and 9(c) of the Plan, upon the earliest of the following: (a) immediately (a)immediately upon the termination of your Continuous Service for Cause; (b) three (b)thirty-six (36) months after the termination of your Continuous Service for any reason other than Cause, your Disability or your death (except as... otherwise provided in Section 8(d) 6(d) below); provided, however, that if during any part of such three thirty-six (36) month period your option is not exercisable solely because of the condition set forth in the section above relating to 4. "Securities Law Compliance," your option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three thirty-six (36) months after the termination of your Continuous Service; provided further, if during any part of such three (3) month period, the sale of any Common Stock received upon exercise of your option would violate the Company's insider trading policy, then your option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three (3) months after the termination of your Continuous Service during which the sale of the Common Stock received upon exercise of your option would not be in violation of the Company's insider trading policy. Notwithstanding the foregoing, if (i) you are a Non-Exempt Employee, (ii) your Continuous Service terminates within six months after the Date of Grant, and (iii) you have vested in a portion of your option at the time of your termination of Continuous Service, your option will not expire until the earlier of (x) the later of (A) the date that is seven months after the Date of Grant, and (B) the date that is three months after the termination of your Continuous Service, and (y) the Expiration Date; (c) 12 (c)thirty-six (36) months after the termination of your Continuous Service due to your Disability (except as otherwise provided in Section 8(d)) 6(d)) below; (d) 18 (d)thirty-six (36) months after your death if you die either during your Continuous Service or within three (3) months after your Continuous Service terminates for any reason other than Cause; (e) the (e)the Expiration Date indicated in your Grant Notice; or (f) the (f)the day before the 10th tenth (10th) anniversary of the Date of Grant. If your option is an Incentive Stock Option, note that to obtain the federal income tax advantages associated with an Incentive Stock Option, the Code requires that at all times beginning on the Date of Grant and ending on the day three months before the date of your option's exercise, you must be an employee of the Company or an Affiliate, except in the event of your death or Disability. The Company has provided for extended exercisability of your option under certain circumstances for your benefit but cannot guarantee that your option will necessarily be treated as an Incentive Stock Option if you continue to provide services to the Company or an Affiliate as a Consultant or Director after your employment terminates or if you otherwise exercise your option more than three months after the date your employment with the Company or an Affiliate terminates. View More

Term. You may not exercise your option before the Date of Grant or after the expiration of the option's its term. The term of your option expires, subject to the provisions terms of Section 5(h) of the Plan, upon the earliest of the following: (a) immediately upon the termination of your Continuous Service for Cause; (b) three months after the termination of your Continuous Service for any reason other than Cause, your Disability or your death (except as otherwise provided in Section 8(d) below); 8(d)); provided, however, that if during any part of such three month period your option is not exercisable solely because of the condition set forth in the section above relating to 4. "Securities Law Compliance," your option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three months after the termination of your Continuous Service; provided further, if during any part of such three (3) month period, the sale of any Common Stock received upon exercise of your option would violate the Company's insider trading policy, then your option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three (3) months after the termination of your Continuous Service during which the sale of the Common Stock received upon exercise of your option would not be in violation of the Company's insider trading policy. Notwithstanding the foregoing, if (i) you are a Non-Exempt Employee, (ii) your Continuous Service terminates within six months after the Date of Grant, and (iii) you have vested in a portion of your option at the time of your the termination of your Continuous Service, your option will not expire until the earlier of (x) (A) the later of (A) (1) the date that is seven months after the Date of Grant, and (B) (2) the date that is three months after the termination of your Continuous Service, and (y) (B) the Expiration Date; Date set forth in your Grant Notice; (c) 12 twelve months after the termination of your Continuous Service due to your Disability (except as otherwise provided in Section 8(d)) below; 8(d)); (d) 18 eighteen months after your death if you die either (i) during your Continuous Service or Service, (ii) within three months after the termination of your Continuous Service terminates for any reason other than Cause; Cause or your Disability, or (iii) within twelve months after the termination of your Continuous Service for your Disability; (e) the Expiration Date indicated in your Grant Notice; or (f) the day before the 10th tenth anniversary of the Date of Grant. If your option is an Incentive Stock Option, note that to obtain the federal income tax advantages associated with an Incentive Stock Option, the Code requires that at all times beginning on the Date of Grant and ending on the day three months before the date of you exercise your option's exercise, option, you must be an employee of the Company or an Affiliate, except in the event of your death or your permanent and total Disability. The Company has provided for extended exercisability of your option under certain some circumstances for your benefit but cannot guarantee that your option will necessarily be treated as an Incentive Stock Option if you continue to provide services to the Company or an Affiliate as a Consultant or Director after your employment terminates or if you otherwise exercise your option more than three months after the date your employment with the Company or an Affiliate terminates. View More

Term. You may not exercise your option before the Date of Grant or after the expiration of the option's term. The term of your option expires, subject to the provisions of Section 5(h) of the Plan, expires upon the earliest of the following: (a) if your Continuous Service is terminated for Cause, then immediately upon the date on which the event giving rise to the termination of your Continuous Service for Cause; Cause first occurred; (b) three (3) months after the termination of your Continuous... Service for any reason other than Cause, your Disability or your death (except as otherwise provided in Section 8(d) below); provided, however, that if during any part of such three (3) month period your option is not exercisable solely because of the condition set forth in the section above relating to 4. "Securities Law Compliance," your option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three months after the termination of your Continuous Service; provided further, if during any part of such three (3) month period, the sale of any Common Stock received upon exercise of your option would violate the Company's insider trading policy, then your option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three (3) months after the termination of your Continuous Service during which the sale of the Common Stock received upon exercise of your option would not be in violation of the Company's insider trading policy. Notwithstanding the foregoing, if (i) you are a Non-Exempt Employee, (ii) your Continuous Service terminates within six months after the Date of Grant, and (iii) you have vested in a portion of your option at the time of your termination of Continuous Service, your option will not expire until the earlier of (x) the later of (A) the date that is seven months after the Date of Grant, and (B) the date that is three months after the termination of your Continuous Service, and (y) the Expiration Date; Service; (c) 12 twelve (12) months after the termination of your Continuous Service due to your Disability (except as otherwise provided in Section 8(d)) 6(d)) below; (d) 18 eighteen (18) months after your death if you die either during your Continuous Service or within three (3) months after your Continuous Service terminates for any reason other than Cause; (e) the Expiration Date indicated in your Grant Notice; or (f) the day before the 10th tenth (10th) anniversary of the Date of Grant. If and to the extent your option is an Incentive Stock Option, note that to obtain the federal income tax advantages associated with an Incentive Stock Option, the Code requires that at all times beginning on the Date of Grant and ending on the day three (3) months before the date of your option's exercise, you must be an employee of the Company or an Affiliate, except in the event of your death or Disability. The Company has provided for extended exercisability of your option under certain circumstances for your benefit but cannot guarantee that your option will necessarily be treated as an Incentive Stock Option if you continue to provide services to the Company or an Affiliate as a Consultant or Director after your employment terminates or if you otherwise exercise your option more than three (3) months after the date your employment with the Company or an Affiliate terminates. View More

Term. You may not exercise your option before the Date of Grant or after the expiration of the option's term. The term of your option expires, subject to the provisions of Section Sections 5(h) and 9(c) of the Plan, upon the earliest of the following: (a) immediately (a)immediately upon the termination of your Continuous Service for Cause; (b) three (b)thirty-six (36) months after the termination of your Continuous Service for any reason other than Cause, your Disability or your death (except as... otherwise provided in Section 8(d) 6(d) below); provided, however, that if during any part of such three thirty-six (36) month period your option is not exercisable solely because of the condition set forth in the section above relating to 4. "Securities Law Compliance," your option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three thirty-six (36) months after the termination of your Continuous Service; provided further, if during any part of such three (3) month period, the sale of any Common Stock received upon exercise of your option would violate the Company's insider trading policy, then your option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three (3) months after the termination of your Continuous Service during which the sale of the Common Stock received upon exercise of your option would not be in violation of the Company's insider trading policy. Notwithstanding the foregoing, if (i) you are a Non-Exempt Employee, (ii) your Continuous Service terminates within six months after the Date of Grant, and (iii) you have vested in a portion of your option at the time of your termination of Continuous Service, your option will not expire until the earlier of (x) the later of (A) the date that is seven months after the Date of Grant, and (B) the date that is three months after the termination of your Continuous Service, and (y) the Expiration Date; (c) 12 (c)thirty-six (36) months after the termination of your Continuous Service due to your Disability (except as otherwise provided in Section 8(d)) 6(d)) below; (d) 18 (d)thirty-six (36) months after your death if you die either during your Continuous Service or within three (3) months after your Continuous Service terminates for any reason other than Cause; (e) the (e)the Expiration Date indicated in your Grant Notice; or (f) the (f)the day before the 10th tenth (10th) anniversary of the Date of Grant. If your option is an Incentive Stock Option, note that to obtain the federal income tax advantages associated with an Incentive Stock Option, the Code requires that at all times beginning on the Date of Grant and ending on the day three months before the date of your option's exercise, you must be an employee of the Company or an Affiliate, except in the event of your death or Disability. The Company has provided for extended exercisability of your option under certain circumstances for your benefit but cannot guarantee that your option will necessarily be treated as an Incentive Stock Option if you continue to provide services to the Company or an Affiliate as a Consultant or Director after your employment terminates or if you otherwise exercise your option more than three months after the date your employment with the Company or an Affiliate terminates. View More

Term. For value received, the Regen BioPharrna, BioPharma, Inc., a Nevada corporation (the "Company") hereby absolutely and unconditionally promises to pay to the order of ___________--("Lender") Caven Investments LLC (the "Lender") ON DEMAND AT ANY TIME AFTER February 28th, May 4, 2021 (the "Maturity Date"), the principal amount of Thirty Thousand Dollars ($30,000) eleven thousand five hundred dollars ($11,500.00) and interest on the whole amount of said principal sum outstanding and remaining from... time to time unpaid (the "Note"), ''Note"), commencing from the date hereof and continuing until payment in full of this Note or conversion as hereinafter provided, at an annual rate equal to ten percent ( 10%) (10%) simple interest. Interest shall be payable quarterly upon demand or upon conversion pursuant to Section 2 hereunder. Interest shall be computed on the basis of the actual number of days elapsed divided by 365. Principal and interest shall be payable in lawful money of the United States of America, at the principal place of business of the Lender or at such other place as the Lender may have designated from time to time in writing to the Company. View More

Term. For value received, the Regen BioPharrna, BioPharma, Inc., a Nevada corporation (the "Company") hereby absolutely and unconditionally promises to pay to the order of ___________--("Lender") ________ ON DEMAND AT ANY TIME THREE YEARS AFTER February 28th, 2021 (the "Maturity Date"), THE Issue Date, the principal amount of Thirty One Hundred Thousand Dollars ($30,000) ($100,000) and interest on the whole amount of said principal sum outstanding and remaining from time to time unpaid (the "Note"),... commencing from the date hereof and continuing until payment in full of this Note or conversion as hereinafter provided, at an annual rate equal to ten eight percent ( 10%) (8%) simple interest. Interest shall be payable quarterly upon demand or upon conversion pursuant to Section 2 hereunder. Interest shall be computed on the basis of the actual number of days elapsed divided by 365. Principal and interest shall be payable in lawful money of the United States of America, at the principal place of business of the Lender or at such other place as the Lender may have designated from time to time in writing to the Company. View More

Term. For value received, the Regen BioPharrna, BioPharma, Inc., a Nevada corporation (the "Company") hereby absolutely and unconditionally promises to pay to the order of ___________--("Lender") Caven Investments LLC (the "Lender") ON DEMAND AT ANY TIME AFTER February 28th, May 4, 2021 (the "Maturity Date"), the principal amount of Thirty Thousand Dollars ($30,000) eleven thousand five hundred dollars ($11,500.00) and interest on the whole amount of said principal sum outstanding and remaining from... time to time unpaid (the "Note"), ''Note"), commencing from the date hereof and continuing until payment in full of this Note or conversion as hereinafter provided, at an annual rate equal to ten percent ( 10%) (10%) simple interest. Interest shall be payable quarterly upon demand or upon conversion pursuant to Section 2 hereunder. Interest shall be computed on the basis of the actual number of days elapsed divided by 365. Principal and interest shall be payable in lawful money of the United States of America, at the principal place of business of the Lender or at such other place as the Lender may have designated from time to time in writing to the Company. View More

Term. For value received, the Regen BioPharrna, BioPharma, Inc., a Nevada corporation (the "Company") hereby absolutely and unconditionally promises to pay to the order of ___________--("Lender") ________ ON DEMAND AT ANY TIME THREE YEARS AFTER February 28th, 2021 (the "Maturity Date"), THE Issue Date, the principal amount of Thirty One Hundred Thousand Dollars ($30,000) ($100,000) and interest on the whole amount of said principal sum outstanding and remaining from time to time unpaid (the "Note"),... commencing from the date hereof and continuing until payment in full of this Note or conversion as hereinafter provided, at an annual rate equal to ten eight percent ( 10%) (8%) simple interest. Interest shall be payable quarterly upon demand or upon conversion pursuant to Section 2 hereunder. Interest shall be computed on the basis of the actual number of days elapsed divided by 365. Principal and interest shall be payable in lawful money of the United States of America, at the principal place of business of the Lender or at such other place as the Lender may have designated from time to time in writing to the Company. View More

Term. The Executive's employment hereunder shall be effective as of commence on the Effective Date and shall continue until the second third anniversary thereof, of the Effective Date, unless terminated earlier pursuant to Section 5 4 of this Agreement; Agreement (the "Initial Term"); provided that, on such first third anniversary of the Effective Date and each annual anniversary thereof thereafter (such date and each annual anniversary thereof, thereof thereafter, a "Renewal Date"), the Agreement... shall be deemed to be automatically extended, upon the same terms and conditions, for successive periods of one year, unless either party provides written notice of its intention not to extend the term of the Agreement at least 90 days' prior to the expiration of the Initial Term or the applicable Renewal Date. Date, as the case may be. Each successive one-year renewal is referred to in this agreement as a "Renewal Term." The period during which the Executive is employed by the Company hereunder is Initial Term together with any Renewal Terms are hereinafter referred to collectively as the "Employment Term." View More

Term. The Executive's employment hereunder shall be effective as of the Effective Date date both Parties have executed this Agreement (the "Effective Date") and shall continue until the second fifth (5th) anniversary thereof, thereof (the "Initial Term"), unless terminated earlier pursuant to Section 5 the terms of this Agreement; provided that, on such first fifth (5th) anniversary of the Effective Date and each third (3rd) annual anniversary thereafter (such date and each annual anniversary... thereof, a "Renewal Date"), the Agreement shall be deemed to be automatically extended, upon the same terms and conditions, for successive periods of one year, three (3) years (each "Renewal Term"), unless either party provides written notice of its intention not to extend the term of the Agreement at least 90 days' days prior to the applicable Renewal Date. The period during which the Executive is employed by the Company hereunder Initial Term and each Renewal Term is hereinafter referred to as the "Employment Term." "Term." View More

Term. The Executive's employment hereunder shall be effective as of July 1, 2021 or such earlier date as shall be agreed to by the Effective Date Executive and the Company (the "Effective Date"), and shall continue until the second third (3rd) anniversary thereof, unless terminated earlier pursuant to Section 5 of this Agreement; provided that, on such first third (3rd) anniversary of the Effective Date and each annual anniversary thereafter (such date and each annual anniversary thereof, a "Renewal... Date"), the Agreement shall be deemed to be automatically extended, upon the same terms and conditions, extended for successive periods of one year, unless either party provides written notice of its intention not to extend the term of the Agreement at least 90 ninety (90) days' prior to the applicable Renewal Date. The period during which the Executive is employed by the Company hereunder is hereinafter referred to as the "Employment Term." "Term". View More

Term. The Executive's employment hereunder shall be effective as of commence on the Effective Date and shall continue until the second third anniversary thereof, of the Effective Date, unless terminated earlier pursuant to Section 5 4 of this Agreement; Agreement (the "Initial Term"); provided that, on such first third anniversary of the Effective Date and each annual anniversary thereof thereafter (such date and each annual anniversary thereof, thereof thereafter, a "Renewal Date"), the Agreement... shall be deemed to be automatically extended, upon the same terms and conditions, for successive periods of one year, unless either party provides written notice of its intention not to extend the term of the Agreement at least 90 days' prior to the expiration of the Initial Term or the applicable Renewal Date. Date, as the case may be. Each successive one-year renewal is referred to in this agreement as a "Renewal Term." The period during which the Executive is employed by the Company hereunder is Initial Term together with any Renewal Terms are hereinafter referred to collectively as the "Employment Term." View More

Term. The Executive's employment hereunder shall be effective as of the Effective Date date both Parties have executed this Agreement (the "Effective Date") and shall continue until the second fifth (5th) anniversary thereof, thereof (the "Initial Term"), unless terminated earlier pursuant to Section 5 the terms of this Agreement; provided that, on such first fifth (5th) anniversary of the Effective Date and each third (3rd) annual anniversary thereafter (such date and each annual anniversary... thereof, a "Renewal Date"), the Agreement shall be deemed to be automatically extended, upon the same terms and conditions, for successive periods of one year, three (3) years (each "Renewal Term"), unless either party provides written notice of its intention not to extend the term of the Agreement at least 90 days' days prior to the applicable Renewal Date. The period during which the Executive is employed by the Company hereunder Initial Term and each Renewal Term is hereinafter referred to as the "Employment Term." "Term." View More

Term. The Executive's employment hereunder shall be effective as of July 1, 2021 or such earlier date as shall be agreed to by the Effective Date Executive and the Company (the "Effective Date"), and shall continue until the second third (3rd) anniversary thereof, unless terminated earlier pursuant to Section 5 of this Agreement; provided that, on such first third (3rd) anniversary of the Effective Date and each annual anniversary thereafter (such date and each annual anniversary thereof, a "Renewal... Date"), the Agreement shall be deemed to be automatically extended, upon the same terms and conditions, extended for successive periods of one year, unless either party provides written notice of its intention not to extend the term of the Agreement at least 90 ninety (90) days' prior to the applicable Renewal Date. The period during which the Executive is employed by the Company hereunder is hereinafter referred to as the "Employment Term." "Term". View More

Term. The term of this Agreement shall commence on the Effective Date and shall continue for a period of three (3) two (2) years following the Effective Date (such initial two (2) year term, the "Initial Term") and shall be automatically renewed for successive one (1) year periods thereafter unless either party provides the other party with written notice of his or its intention not to renew this Agreement at least three (3) months prior to the expiration of the initial term or any renewal term of... this Agreement. "Employment Period" shall mean the initial three (3)-year two (2) year term plus one (1)-year renewals, if any. View More

Term. The term of this Agreement shall commence on the Effective Date and shall continue for a period of three (3) years one (1) year following the Effective Date and shall be automatically renewed for successive one (1) year periods thereafter unless either party provides the other party with written notice of his or its intention not to renew this Agreement at least three (3) months prior to the expiration of the initial term or any renewal term of this Agreement. "Employment Period" shall mean the... initial three (3)-year one (1) year term plus one (1)-year renewals, if any. View More

Term. The term of this Agreement shall commence on the Effective Date and shall continue for a period of three (3) years one (1) year following the Effective Date and shall be automatically renewed for successive one (1) year periods thereafter unless either party provides the other party with written notice of his or its intention not to renew this Agreement at least three (3) months prior to the expiration of the initial term or any renewal term of this Agreement. "Employment Period" shall mean the... initial three (3)-year one (1)-year term plus one (1)-year renewals, if any. View More

Term. The term of this Agreement shall commence on the Effective Date and shall continue for a period of three (3) two (2) years following the Effective Date (such initial two (2) year term, the "Initial Term") and shall be automatically renewed for successive one (1) year periods thereafter unless either party provides the other party with written notice of his or its intention not to renew this Agreement at least three (3) months prior to the expiration of the initial term or any renewal term of... this Agreement. "Employment Period" shall mean the initial three (3)-year two (2) year term plus one (1)-year renewals, if any. View More

Term. The term of this Agreement shall commence on the Effective Date and shall continue for a period of three (3) years one (1) year following the Effective Date and shall be automatically renewed for successive one (1) year periods thereafter unless either party provides the other party with written notice of his or its intention not to renew this Agreement at least three (3) months prior to the expiration of the initial term or any renewal term of this Agreement. "Employment Period" shall mean the... initial three (3)-year one (1) year term plus one (1)-year renewals, if any. View More

Term. The term of this Agreement shall commence on the Effective Date and shall continue for a period of three (3) years one (1) year following the Effective Date and shall be automatically renewed for successive one (1) year periods thereafter unless either party provides the other party with written notice of his or its intention not to renew this Agreement at least three (3) months prior to the expiration of the initial term or any renewal term of this Agreement. "Employment Period" shall mean the... initial three (3)-year one (1)-year term plus one (1)-year renewals, if any. View More

Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 Exhibit 10.4 SERES THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Inc. (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this... "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall will become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock March 1, 2019 (the "Effective Date"). As of the Effective Date, the terms and conditions of this Program will supersede any prior cash and/or equity compensation arrangements for service as a member of the Board that are not legally binding contracts between the Company and any of its Non-Employee Directors. I. CASH COMPENSATION A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $40,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. Board. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $45,000 for such service. View More

Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 EX-10.3 9 d72917dex103.htm EX-10.3 EX-10.3 Exhibit 10.4 SERES 10.3 FREQUENCY THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Frequency Therapeutics, Inc. (the "Company") shall receive cash and equity compensation as... set forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION Cash Compensation A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $30,000 for such service. View More

Term. The maximum term of each stock share option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 3 EX-10.1 2 knsa-20190930ex101435496.htm EX-10.1 knsa_Ex10_1 Exhibit 10.4 SERES THERAPEUTICS, INC. 10.1 KINIKSA PHARMACEUTICALS, LTD. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Inc. Kiniksa Pharmaceuticals,... Ltd. (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this (as amended effective as of October 1, 2019, this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). hereunder. I. CASH COMPENSATION A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $40,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $30,000 for such service. View More

Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 Exhibit 10.4 SERES THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Inc. (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this... "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall will become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock March 1, 2019 (the "Effective Date"). As of the Effective Date, the terms and conditions of this Program will supersede any prior cash and/or equity compensation arrangements for service as a member of the Board that are not legally binding contracts between the Company and any of its Non-Employee Directors. I. CASH COMPENSATION A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $40,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. Board. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $45,000 for such service. View More

Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 EX-10.3 9 d72917dex103.htm EX-10.3 EX-10.3 Exhibit 10.4 SERES 10.3 FREQUENCY THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Frequency Therapeutics, Inc. (the "Company") shall receive cash and equity compensation as... set forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION Cash Compensation A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $30,000 for such service. View More

Term. The maximum term of each stock share option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 3 EX-10.1 2 knsa-20190930ex101435496.htm EX-10.1 knsa_Ex10_1 Exhibit 10.4 SERES THERAPEUTICS, INC. 10.1 KINIKSA PHARMACEUTICALS, LTD. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Inc. Kiniksa Pharmaceuticals,... Ltd. (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this (as amended effective as of October 1, 2019, this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). hereunder. I. CASH COMPENSATION A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $40,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $30,000 for such service. View More